Company intelligence / Profile preview
Precision BioPharma
- Ownership
- Private
- Development stage
- Other
Overview
Precision BioPharma enables biopharmaceutical partners to develop new precision medicines by providing advanced patient stratification solutions. Their approach helps identify which drugs will work best for specific patient subgroups, aiming to improve R&D productivity, reduce late-stage clinical trial failures due to poor efficacy in unstratified populations, and support successful product launches with outcomes-based remuneration models.[1] There is no public information about their own clinical programs.
- Therapeutic areas
- Other
- Modalities
- small moleculesbiologicsbiomarker-based approaches
- Industry
- Drug Discovery Services
Drug pipeline
1 assetBeyond the preview
Go deeper on Precision BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Precision BioPharma.